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A B S T R A C T   
Previous risk assessments have concluded that adolescent’s caffeine exposure from energy drinks (ED) are of 
limited concern. Recent surveys have, however, shown substantial increase in consumption. This cross-sectional 
survey conducted in 2020 estimated caffeine exposure from beverages among ~80% of all 13-15-year-old ad-
olescents (n = 10358) relative to the European Food Safety Authority’s level of no safety concern of (3.0 mg/kg 
bw) and level for effects on sleep (1.4 mg/kg bw). Associations with self-reported sleep duration and quality were 
also explored. ED consumers were more likely to exceed the limit of no safety concern (prevelance: 12–14%) 
compared to non-ED-consumers (1–2%). Exceeding the limit for effects on sleep was also higher among ED 
consumers (31–38%) than non-ED-consumers (5–8%). Across categories of low (<0.5 mg/kg bw) to high (>3.0 
mg/kg bw) caffeine intake, the prevalence of participants sleeping <6 h increased from 3% to 24%, respectively. 
The corresponding adjusted Prevalence Ratio was 4.5 (95% CI: 3.6, 5.7) and mean decrease in duration of sleep 
was 0.74 h (95% CI: 0.65, 0.84). In conclusion, caffeine intake from beverages above the limit of no safety 
concern was largely confined to ED consumers. Consistent with effects from intervention studies in adults, 
caffeine intake was strongly associated with self-reported sleep duration in this representative population.   
1. Introduction 
Energy drinks are non-alcoholic beverages that contain a relatively 
high amount of caffeine compared to other soft drinks and are often 
marketed as boosting athletic performance or mental alertness. Con-
cerns about energy drinks as determinant of high caffeine exposure in 
children have been raised due to possible adverse effects of caffeine on 
neurological and cardiovascular outcomes; as well as risk of acute 
toxicity at the extremes (Ehlers et al., 2019; Temple, 2009). In adults, 
mild symptoms of caffeine toxicity (at~0.75 g) include gastric symp-
toms, seizures and fever; and the lowest lethal dose recorded is ~5 g 
(OECD-SIDS, 2002). Due to differences in body weight (bw), the same 
effects will occur at proportionally lower intakes in children (EFSA, 
2015), but poisoning events appear rare based on the few reports 
available (Ehlers et al., 2019; Seifert et al., 2013). Studies focusing on 
children are also scarce (Wikoff et al., 2017), but habitual intake has 
been linked with physical dependence, sleep- and mood disorders 
(Cusick et al., 2020; Jackson et al., 2013; Kristjansson et al., 2014; 
Owens et al., 2014; Pollak and Bright, 2003) 
There are currently no specific guidelines on caffeine intake in the US 
for children, while Health Canada established in 2012 a recommended 
level of 2.5 mg/kg bw (Health Canada, 2012). Three years later the 
European Food Safety Authority (EFSA) published a risk assessment on 
caffeine where a single dose of caffeine of up to 200 mg (or ~3 mg/kg 
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bw), and habitual daily caffeine intake of 400 mg (5.7 mg/kg bw) was 
set as the level of no safety concern for non-pregnant healthy adults 
(EFSA, 2015). It was also noted that a single dose of 100 mg (~1.4 
mg/kg bw) consumed close to bedtime could affect sleep latency and 
duration. For pregnant or lactating women, the opinion stated that 
habitual caffeine intake up to 200 mg per day would not give rise to 
safety concerns. Citing lack of data, EFSA set as a precaution for children 
and adolescents, a level of no safety concern of 3 mg/kg bw per day for 
habitual caffeine consumption. 
Until 2008 the maximum limit in Iceland for caffeine added to soft 
drinks was (150 mg/L) but gradually concentrations increased to ~320 
mg/L and in 2017 energy drinks with a concentration of up to ~550 mg/ 
L first appeared on the market. Coincidingly, nationwide surveys among 
adolescents showed that consumption of energy drinks had more than 
doubled between 2016 and 2018 (Guðmundsdóttir et al., 2019). Con-
cerns about the possible deleterious effects of the aforementioned in-
crease in energy drink consumption prompted a more detailed 
assessment of caffeine intake from beverages among all 13 to 15-year--
old children in Iceland in 2020. The aim of this study was to assess 
possible risks associated with caffeine consumption from beverages 
relative to the level of no safety concern set by EFSA (EFSA, 2015); and 
to assess whether intake of caffeine from beverages might be adversely 
associated with sleep duration and quality in these children. 
2. Materials and methods 
2.1. Survey description 
In January 2020, the Icelandic Risk Assessment Committee for Food, 
Feed, Fertilizers and Seeds under the Ministry of Industries and Innovation 
was asked to perform a quantitative assessment on caffeine intake from 
beverages. Data was collected using the Youth in Iceland survey; a 
biannual paper-and-pencil questionnaire survey, conducted by the Ice-
landic Centre for Social Research and Analysis, that collects social 
behavioural health information for policy, research and prevention 
(Kristjansson et al., 2016; Sigfusdottir et al., 2020). The survey was 
conducted in February of 2020 and was administered according to 
standard protocols (Kristjansson et al., 2013) to all 13-15-year-old 
children across 135 schools in Iceland. The full questionnaire, avail-
able in Icelandic and English, was designed to be completed within one 
40 min class session. 
All aspects of data collection, including participant involvement 
based on passive parental/caregiver consent, were in compliance with 
Icelandic law on the protection of human subjects that have been 
reviewed and deemed exempt by the Icelandic National Bio-Ethics 
Committee (similar to a National IRB; protocol # VSNb2017020009/ 
04.01). 
2.2. Study size 
A total of 10778 children returned the questionnaire corresponding 
to ~80% of all 13-15-year-old children in Iceland. The present analyses 
were conducted with 10358 children who provided answers on 
caffeinated beverages (96% of responders). Due to missing values on the 
sleep duration and sleep quality questions, analyses of those data were 
based on 10225 to 10324 children (95–96% of responders). 
2.3. Quantification of caffeine intake 
Previous Youth in Iceland surveys have included questions on energy 
drinks, cola drinks, coffee and tea in categories of never or number of 
servings per day. For the purpose of our assessment, capturing a broader 
habitual intake was considered important but replacing existing ques-
tions would have hampered comparison with previous surveys. Existing 
questions were therefore kept but new questions on energy drinks, 
caffeinated protein sports drinks (mixed from powder) and cola drinks 
were added with a scale of never, <1/week, 2–3/week, 4–6/week, 1/day, 
2/day and ≥3/day. For all beverages, the children were asked to report 
their current level of consumption. Total caffeine intake from beverages 
was then quantified based on the reported frequency of intake from the 
new questions as well as the original questions on coffee and tea. The 
justification for relying on the older questions for coffee and tea was that 
consumption of these beverages would, based on previous surveys, be 
low and limiting the number of added questions was important. Exact 
response categories and the frequency distributions for individual bev-
erages are shown in Supplemental Table S1 and all questions from the 
survey (in Icelandic) relevant to the results presented in this paper are 
included in the online supplemental material. 
The caffeine content in energy drinks was assessed with the 
following question: “when you drink energy dinks what is the amount of 
caffeine content usually declared in mg on the can or bottle“. Possible re-
sponses were ~80 mg, ~105 mg, ~180 mg, and "don’t know". These 
options referred to the absolute amount of caffeine per serving based on 
the most frequent concentrations declared on energy drinks on the 
market in Iceland in 2019. This method for quantification was used as 
the absolute caffeine content (in mg) is usually clearly labelled on these 
beverages and is easier to understand than concentrations in mg/L 
which need to be considered in relation to serving size. The amount of 
caffeine in protein sports drinks mixed from powder was assumed to 
contain 50 mg/serving based on declaration from prevalent products on 
the market. The amount of caffeine assigned to coffee was 100 mg/ 
serving averaged over all different types of coffee that vary in both 
serving size and concentration. For tea the caffeine concentration was 
estimated to be 28 mg/serving assuming a standard serving size of 150 
mL and assuming a 50%/50% mixture of black (220 mg caffeine/L) and 
green (151 mg caffeine/L) tea. For cola beverages the caffeine concen-
tration was estimated to be 36 mg/serving assuming caffeine concen-
tration of 108 mg/L and standard serving size of 330 mL. These 
estimates were largely based on the values used to assess caffeine intake 
by EFSA (EFSA, 2015). 
Based on these assumptions the total amount of caffeine from each 
beverage was estimated by multiplying the frequency of consumption 
for each individual with the estimated amount of caffeine from each 
beverage. The total amount of caffeine from beverages was then calcu-
lated as the sum of all the five beverages. 
2.4. Questionnaire information 
The Youth in Iceland survey contains several questions on socio- 
demographics, height and weight. Participants were also asked to self- 
rate their mental and physical health (as very good, good, adequate, 
poor or very poor); and to report their engagement in sports (frequency 
per week). Questions capturing their temperament and mental well-
being were also included. In those questions participants were asked to 
report how frequently during the previous week they had experienced 
episodes of nervousness, anxiety, being angry and running into argu-
ments. Questions on episodes of headaches and stomach pains during 
the previous week were also included. Participants were also asked to 
assess their duration and quality of sleep, in terms of 1) average duration 
in hours and 2) difficulties in falling asleep or staying asleep. 
2.5. Main outcomes 
To assess possible risks associated with caffeine intake from bever-
ages, quantified intake was compared to the EFSA level of no safety 
concern set as 3.0 mg/kg bw for children and adolescents (EFSA, 2015). 
This level is primarily set on the basis of effects of caffeine on the car-
diovascular system. Quantified intake of caffeine was also compared to 
the cut-off of 1.4 mg/kg bw, which EFSA has proposed as the threshold 
for a single dose that may affect sleep. 
Questions on duration of sleep (response categories <6, ~6, ~7, ~8, 
~9, >9 h/day) and on difficulty falling asleep were used to assess 
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possible influence of caffeine intake on the children’s wellbeing. The 
reason for using these outcomes is that there is strong evidence for a 
causal link between caffeine consumption and reductions in sleep 
quantity and quality, especially when the caffeine is consumed in large 
doses and/or too close to bedtime (Drake et al., 2013; EFSA, 2015; 
Landolt et al., 1995a; Roehrs and Roth, 2008). Furthermore, it is also 
well established that poor sleep duration and quality can affect chil-
dren’s mental and physical health (Freeman et al., 2017; Shochat et al., 
2014). 
2.6. Statistical analyses 
Prevalence of consumption for caffeinated beverages, defined as any 
intake above the zero category, was reported along with distributions of 
total caffeine intake in both absolute amount (mg) and relative to body 
weight (mg/kg bw). Percent of subjects above EFSAs level of no safety 
concern (3.0 mg/kg bw) and cut-off for sleep (1.4 mg/kg bw) was 
evaluated. Habits related to caffeine intake were described by 
comparing participants response to questions on engagement in sports, 
fitness level, mental health, and physical symptoms across categories of 
caffeine exposure (<0.5, 0.5–1.0, >1.0–1.4, >1.4–3.0, >3.0 mg/kg bw). 
The chi-square and the F-test were used to test for differences across 
categories for dichotomous and continuous variables, respectively. 
Association between caffeine intake and sleep were examined for 
three outcomes: 1) having an average sleeping duration <6 h/night 
(binary outcome), 2) having difficulties in falling or staying asleep (bi-
nary outcome) and 3) mean duration of sleep (in hours/night, contin-
uous outcome). To address possible reverse causation, e.g., that 
participants with poor physical or mental health or other conditions 
known to affect sleep might consume more caffeine to compensate, 
stratified associations across such conditions were examined. Associa-
tions with the two binary outcomes were evaluated by multivariate log- 
binomial regression as implemented in proc genmod in SAS (version 9.2) 
estimating prevalence ratios (Richardson et al., 2015) using low caffeine 
intake (<0.5 mg/kg bw) as referent. Relative change in sleep (in hours) 
was evaluated using multivariate linear regression using the same 
referent. In all analyses the following set of covariates were included: sex 
(binary variable, 0.5% missing), age (categorical, 3 levels, 0.6% 
missing), overweight (binary variable, 11% missing); and self-reported 
mental and physical health (categorical variables, 5 levels; 3.0% and 
2.9% missing, respectively). Prevalence of overweight was assessed 
based on self-reported weight and height using age and gender specific 
cut-offs (Cole et al., 2000). Missing covariate information were imputed 
using multiple imputation (n = 5) as implemented in proc MI in SAS. 
3. Results 
Characteristics of study participants are shown in Table 1. Preva-
lence of energy drink consumption (any intake above the zero category) 
was comparable in both sexes and increased from 30% in 13-year-old 
boys to 47% in 15-year-old boys and from 26% in 13-year-old girls to 
48% in 15-year-old girls. Prevalence of cola drink consumption varied 
less with age and was slightly more prevalent among boys (range: 
73–75%) compared to girls (range: 60–64%). The prevalence for con-
sumption of other caffeinated beverages was considerably lower 
(≤24%). The full frequency distribution for all these beverages is shown 
in Supplemental Table S1 and the mean contribution of each beverage to 
total caffeine intake among energy drink consumers and non-consumers 
is shown in Table 2. 
Table 3 shows the distribution of total caffeine intake from beverages 
(in mg/day) for both sexes combined. The prevalence of subjects above 
the level of no safety concern (>3.0 mg/kg bw) ranged from 4% to 8% 
between the ages of 13–15 years. The number of subjects above the cut- 
off for sleep (>1.4 mg/kg bw) was around 3-fold higher, or 13%–22%, 
respectively. Among non-energy drink consumers, percentage 
consuming above the level of no safety concern and above the cut-off for 
sleep ranged between 1-2% and 5–9%, respectively. However, for en-
ergy drink consumers the corresponding numbers were 12–14% and 
31–38%, respectively. The majority of energy drink consumers (≥90%) 
could identify the concentration of their preferred energy dinks, with 
105 mg caffeine per serving being the most prevalent choice (Supple-
mental Table S2). Around 10% of boys and 5% of girls reported 
preferred consumption of energy drinks containing 180 mg caffeine per 
serving. 
Higher consumption of caffeine (in mg/kg bw) was associated with 
worse physical and mental health compared to those with lower intake 
(Table 4). Those with higher intake were also less likely to engage in 
sports and were more frequently lonely, angry, nervous, and anxious. 
Episodes of headaches and stomach aches were also more common at 
higher caffeine intakes. 
Across categories of low (<0.5 mg/kg bw) to high (>3.0 mg/kg bw) 
caffeine intake, the prevalence of subjects sleeping <6 h increased from 
3% to 24%, respectively (Table 5). The corresponding adjusted Preva-
lence Ratio (PR) was 4.5 (95% confidence interval (CI): 3.6, 5.7) Simi-
larly, the prevalence of having difficulty falling asleep increased from 
Table 1 
Characteristics of study participants in the Youth in Iceland survey 2020 
(n=10358).   
13 years 14 years 15 years  
Mean (standard deviation), or % 
Boys n = 1825 n = 1721 n = 1654 
Weight, kg 56 (11) 63 (11) 68 (11) 
Height, cm 168 (9) 173 (8) 178 (7) 
% overweighta 16% 15% 15% 
Consumers of caffeinated beveragesb   
Energy drinks 30% 39% 47% 
Caffeinated protein sports drinks 11% 13% 20% 
Cola drinks 75% 78% 73% 
Coffee 6% 8% 12% 
Tea 21% 20% 15% 
Girls n = 1813 n = 1689 n = 1656 
Weight, kg 54 (10) 58 (9) 61 (9) 
Height, cm 164 (7) 165 (6) 167 (6) 
% overweighta 15% 15% 15% 
Consumers of caffeinated beveragesb  
Energy drinks 26% 35% 48% 
Caffeinated protein sports drinks 6% 7% 13% 
Cola drinks 64% 62% 60% 
Coffee 7% 7% 11% 
Tea 24% 21% 20%  
a Age specific cut-off for overweight as defined by Cole TJ et al. (Cole et al., 
2000). 
b Any intake reported above the zero category based on participants response 
to questions on their current consumption of these beverages. The exact fre-
quency distribution for the participants responses are shown in Supplemental 
Table S1 
Table 2 
The average (in mg) and relative (in %) contribution of the different caffeinated 
beverages to total caffeine intake. The results are shown for energy drink con-
sumersa and non-consumers separately.   
Mean caffeine intake in mg (%of total)  




Total from all beverages 94 mg (− ) 23 mg (− ) 
energy drinks 46 mg (49%) 0 mg (0%) 
cola drinks 15 mg (16%) 8 mg (35%) 
caffeinated sports 
drinks 
4 mg (4%) 1 mg (<1%) 
Coffee 20 mg (21%) 6 mg (26%) 
Tea 9 mg (10%) 7 mg (30%)  
a Any intake reported above the zero-category based on participants response 
to questions on their current consumption of these beverages. 
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13% to 31% across categories from low (<0.5 mg/kg bw) to high (>3.0 
mg/kg bw) caffeine intake with adjusted prevalence ratio of 1.7 (95% 
CI: 1.4, 2.0). The corresponding mean decrease in duration of sleep was 
0.74 h (95% CI: 0.65, 0.84). 
When comparing high (>3.0 mg/kg bw) versus low (<0.5 mg/kg 
bw) caffeine intake in stratified analyses (Table 5) relatively strong as-
sociation with sleeping <6 h were observed in strata of those reporting 
either good or very good [PR: 8.2 (95%: 5.4, 12.7)] or adequate, poor 
and very poor mental health [PR: 3.7 (95%CI: 2.9, 4.9)]. In absolute 
terms the proportion of participants affected was larger among those 
with adequate, poor or very poor mental health (34% at >3.0 mg/kg - 
7% at <0.5 mg/kg = 27%) compared to those with good or very good 
mental health (12% at >3.0 mg/kg - 1% at <0.5 mg/kg = 11%). To test 
the stability of our findings in these stratified analyses we also examined 
the influence of excluding those reporting adequate health from the 
strata of those with adequate to very poor mental health. After exclu-
sion, the mean reduction in sleep duration when comparing those with 
caffeine intake >3.0 mg/kg vs. <0.5 mg/kg was 0.86 h (95%CI: 0.64, 
1.07), which is near identical to the estimate reported in Table 4 when 
the adequate group was included [0.87 h (95%CI: 0.73, 1.01)]. As 
further stability analysis, associations with sleeping <7 h were also 
examined (Supplemental Table S3) and the results concur with our 
primary analyses in Table 5. 
Similar patterns of consistent associations between caffeine con-
sumption and sleep duration were also observed across strata of several 
other self-reported conditions that might affect sleep duration (Table 6). 
4. Discussion 
In a nationwide survey of Icelandic adolescents with ~80% popu-
lation coverage, the prevalence of energy drink consumption was ~30% 
in 13 year old adolecents but increased to ~50% at age 15 years. Energy 
drink consumers were more likely to exceed the caffeine limit of no 
safety concern (prevalence: 12–14%) set by EFSA, compared to non- 
consumers (prevalence: 1–2%). The proportion of those exceeding the 
limit for effects on sleep duration and latency was also much higher 
among energy drink consumers (31–38%) than non-consumers (5–9%). 
Total caffeine intake from beverages was strongly associated with self- 
reported measures of both poor sleep duration and difficulty falling 
asleep and this association was stable across conditions and behaviours 
known to affect sleep. 
National legislations and recommendations on caffeine vary 
considerably (Reyes and Cornelis, 2018). In Iceland, the limit for 
caffeine in soft drinks was previously set at 150 mg/L but in 2007 the 
European Commission filed objections to this low value citing free 
movement of goods within the EU (MAST, 2019). The EFSA opinion 
from 2015 (EFSA, 2015) was intended to provide more scientific clarity 
as such opinions provide scientific basis for policies and legislative de-
cisions on food safety in the EU. In their opinion EFSA established a level 
of no safety concern for caffeine, which is a threshold below which no 
Table 3 
Distribution of caffeine intake (in mg/day) from beverages and prevalence of subjects above the reference value for effect on sleep (1.4 mg/kg bw)a and level of no 
safety concern (3.0 mg/kg bw)a. Youth in Iceland survey 2020 (n = 10358).   
mg of caffeine/day 
5, 10, 25 50, 75, 90 and 95th percentile 
Above cut-off for sleep (>1.4 mg/kg bw) Above Level of no safety concern 
>3.0 mg/kg bw 
All subjects    
15 years (n=3310) 0, 0, 3, 26, 78, 158, 238 22% 8% 
14 years (n=3410) 0, 0, 3, 13, 48, 128, 196 16% 5% 
13 years (n=3638) 0, 0, 3, 13, 37, 101,146 13% 4% 
Non-energy drink consumers   
15 years (n=1761) 0, 0, 0, 5, 28, 74, 126 9% 2% 
14 years (n=2156) 0, 0, 0, 5, 26, 54, 103 6% 1% 
13 years (n=2620) 0, 0, 0, 5, 28, 41, 87 5% 1% 
Energy drink consumers   
15 years (n=1549) 10, 11, 25, 58, 132, 231, 327 38% 14% 
14 years (n=1254) 10, 11, 21, 49, 113, 216, 311 33% 13% 
13 years (n=1018) 8, 10, 20, 41, 98, 187, 295 31% 12%  
a as established by EFSA 2015: Scientific Opinion on the safety of caffeine (EFSA, 2015). 
Table 4 
Self-reported mental health, physical form, and conditions reflecting wellbeing 
of participants according to their caffeine intake from beverages. Youth in Ice-
land survey 2020 (n = 10358).   
mg/kg body weight P-valuea  
<0.5 0.5–1.0 >1.0–1.4 >1.4–3.0 >3.0 
Mental health     
How do you describe your mental health   <0.0001 
Very good 32% 24% 21% 21% 18%  
Good 38% 40% 37% 31% 30%  
Adequate 20% 23% 25% 28% 28%  
Poor 7% 10% 13% 13% 15%  
Very poor 3% 4% 5% 7% 9%  
Physical form and sports     
Sports ≥3/ 
wk. 
86% 84% 84% 76% 74% <0.0001 
How do you describe your physical condition    
Very good 40% 32% 27% 24% 22% <0.0001 
Good 39% 41% 39% 39% 38%  
Adequate 18% 22% 27% 29% 29%  
Poor 3% 4% 5% 7% 9%  
Very poor 0% 1% 2% 1% 2%  
Feeling unwell2       
Frequent 
headaches 




10% 14% 15% 18% 19% <0.0001 
Relations and friendshipa      
Often lonely 10% 14% 13% 18% 18% <0.0001 
Temperament 2      
Often angry 3% 5% 7% 7% 11% <0.0001 
Frequently 
nervous 
9% 10% 11% 14% 13% <0.0001 
Often anxious 7% 8% 11% 13% 14% <0.0001 
Frequent 
arguments 
4% 6% 8% 12% 15% <0.0001 




13% 18% 20% 25% 31% <0.0001 
Sleeping <6 h 3% 5% 7% 11% 24% <0.0001  








7.3 (1.2) 7.1 (1.2) 6.8 
(1.4) 
<0.0001  
a Chis-square test; 2 In the questionnaire it was asked, “How often did you feel 
or experience any of the following feelings or conditions during the previous 
week?”. The reported percentages refer to those who answered yes to these 
conditions occurring "often "or "frequently." 
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Table 5 
Caffeine intake from beverages and its associationa with sleep duration and difficulty falling asleep. Results are presented for all subjects and stratified by participants 
self-reported mental health. Youth in Iceland survey 2020 (N = 10225–10324)b.  
Caffeine intake mg/kg body weight Sleeping less than 6 hc Difficulty falling asleep Change in duration of sleep (hours) c  
no. cases (%)/N PR (95%CI) no. cases (%)/N PR (95%CI) mean (95%CI) 
All      
<0.5 192 (3%)/6307 1.00 782 (13%)/6249 1.00 referent 
0.5–1.0 88 (5%)/1725 1.5 (1.1, 1.9) 302 (18%)/1707 1.2 (1.1, 1.4) − 0.20 (− 0.26, − 0.15) 
>1.0–1.4 36 (7%)/541 1.6 (1.0, 2.2) 109 (20%)/538 1.3 (1.1, 1.6) − 0.30 (− 0.40, − 0.21) 
>1.4–3.0 129 (11%)/1147 2.5 (2.0, 3.1) 281 (25%)/1134 1.4 (1.3, 1.7) − 0.49 (− 0.55, − 0.42) 
>3.0 143 (24%)/604 4.5 (3.6, 5.7) 184 (31%)/597 1.7 (1.4, 2.0) − 0.74 (− 0.84, − 0.65) 
P for trende  <0.0001  <0.0001 <0.0001 
Very good or good mental healthd    
<0.5 61 (1%)/4437 1.00 283 (6%)/4392 1.00 referent 
0.5–1.0 20 (2%)/1080 1.4 (0.8, 2.3) 100 (9%)/1069 1.3 (1.1, 1.7) − 0.19 (− 0.26, − 0.13) 
>1.0–1.4 6 (2%)/315 1.3 (0.5, 3.0) 30 (10%)/312 1.4 (1,0, 2.2) − 0.35 (− 0.47, − 0,23) 
>1.4–3.0 25 (4%)/599 2.8 (1.8, 4.5) 69 (12%)/593 1.8 (1.4, 2.3) − 0.48 (− 0.57, − 0.39) 
>3.0 35 (12%)/288 8.2 (5.4, 12.7) 41 (14%)/286 2.2 (1.6, 3.1) − 0.64 (− 0.77, − 0.52) 
P for trende  <0.0001  <0.0001 <0.0001 
Adequate poor or very poor mental healthd     
<0.5 131 (7%)/1870 1.00 499 (27%)/1857 1.00 referent 
0.5–1.0 68 (11%)/645 1.5 (1.1, 2.0) 202 (32%)/638 1.1 (1.0, 1.4) − 0.24 (− 0.34, − 0.13) 
>1.0–1.4 30 (13%)/226 1.6 (1.0, 2.5) 79 (35%)/226 1.3 (1.0, 1.6) − 0.26 (− 0.43, − 0,10) 
>1.4–3.0 104 (19%)/548 2.4 (1.8, 3.1) 212 (39%)/541 1.3 (1.1, 1.6) − 0.52 (− 0.63, − 0.41) 
>3.0 108 (34%)/316 3.7 (2.9, 4.9) 143 (46%)/311 1.5 (1.3, 1.8) − 0.87 (− 1.01, − 0.73) 
P for trende  <0.0001  <0.0001 <0.0001 
Abbreviations: PR, prevalence ratio; CI, confidence interval. 
a adjusted for sex, age, overweight and self-reported mental and physical health. 
b N = 10324 for sleeping less than 6 h and duration of sleep; N = 10225 for difficulty falling asleep. 
c This outcome is based on the question: “How many hours do you sleep on average per night” with responses of <6, ~6, ~7, ~8, ~9 and > 9 h. 
d The participants were asked to rate their mental health as: very good, good, adequate, poor, and very poor. 
e Caffeine intake in mg/kg body weight entered as continuous variable in the regression model using the median values for each category. T-test for duration of sleep, 
otherwise Chi-square test. 
Table 6 
Caffeine intake from beverages and its associationa with duration and difficulty falling asleep stratified by self-reported symptoms of physical, social, and mental 
conditions that may affect sleep quality. Youth in Iceland survey 2020.   
Caffeine Sleep <6 h Change in duration of sleep (hours)  
mg/kg bw No cases/N PR (95% CI) mean (95%CI) 
Physical healthb     
Good ≤1.0 121 (2%)/6163 1.0 Referent 
>1.4 104 (10%)/1086 3.7 (2.8, 4.8)) − 0.52 (− 0.59, − 0.46) 
Adequate/poor ≤1.0 159 (9%)/1869 1.0 Referent 
>1.4 168 (25%)/665 2.4 (1.9, 3.0) − 0.52 (− 0.62, − 0.41) 
Engagement in sports     
≥3/week ≤1.0 196 (3%)/6856 1.0 Referent 
>1.4 180 (14%)/1323 3.1 (2.5, 3.8) − 0.53 (− 0.59, − 0.47) 
<3/week ≤1.0 84 (7%)/1092 1.0 Referent 
>1.4 92 (22%)/528 2.5 (1.8, 3.3) − 0.48 (− 0.61, − 0.35) 
Frequent stomach- or headachesc    
No ≤1.0 158/(2%)/6579 1.0 Referent 
>1.4 141 (11%)/1269 3.2(2.5, 4.0) − 0.50 (− 0.56, − 0.44)     
Yes ≤1.0 122 (8%)/1453 1.0 Referent 
>1.4 131 (27%)/482 2.4 (1.8, 3.1) − 0.56 (− 0.68, − 0.44) 
Often lonelyb     
No ≤1.0 184 (3%)/7148 1.0 Referent 
>1.4 180 (12%)/1444 3.4 (2.7, 4.2) − 0.52 (− 0.58, − 0.46)      
Yes ≤1.0 96/11%)/884 1.0 Referent 
>1.4 92 (30%)/307 2.2 (1.6, 2.9) − 0.55 (− 0.71, − 0.39) 
Frequently angry, nervous, anxious, or arguingb   
No ≤1.0 138 (2%)/6710 1.0 Referent 
>1.4 125 (10%)/1239 3.5 (2.7, 4.5) − 0.48 (− 0.54, − 0.42)      
Yes ≤1.0 137 (11%)/1245 1.0 Referent 
>1.4 145 (29%)/505 2.1 (1.7, 2.7) − 0.58 (− 71, − 0.45) 
Abbreviations: PR, prevalence ratio; CI, confidence interval. 
a Adjusted for sex, age, overweight and self-reported mental and physical health. 
b The participants were asked to rate their physical health as: very good, good, adequate, poor, and very poor. 
c In these questions asked, “How often did you feel or experience any of the following feelings or conditions during the previous week?”. 
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health risk is expected (EFSA, 2015). This is a more uncertain value 
compared to other health-based guidance values set for substances 
intentionally added to foods (e.g. Acceptable Daily Intake), where ex-
ceedance is more clearly linked to adversity. We can therefore only 
conclude that between the ages of 13–15 years, caffeine intake among 
4%–8% of our participants may pose some risks to their health. 
Although documented cases of acute toxicity are rare (Seifert et al., 
2013), such events may become more frequent with rapidly rising 
prevalence of excessive consumption and increased availability of 
products with high caffeine content. Despite restrictions in Iceland on 
selling heavily caffeinated energy drinks (180 mg/serving) to children 
(<18 years), around 10% of energy drink consumers in our study re-
ported both preference for, and consumption of, such beverages. How-
ever, focusing on toxicological outcomes alone overlooks other health 
aspects, including effects on sleep and the fact that part of those who 
drink caffeinated beverages on regular basis develop caffeine de-
pendency and experience withdrawal symptoms, including headache, 
fatigue, and anxiety that for some can last several days (Bernstein et al., 
1998; Juliano and Griffiths, 2004). This is not the case for any other 
substances intentionally added to foods. Intentional enrichment of soft 
drinks and other foods with caffeine that can be marketed and sold 
unrestricted to children, which may result in physical dependency, 
largely appears to fall outside the remit of food safety as defined by the 
general EU food law (European Parliament, 2002), which primarily fo-
cuses on protecting consumers from foods that are “injurious to health”. 
Under such remit effects on physical dependency and sleep that are well 
established in adults may, from a toxicological point of view, not meet 
the definition of being adverse or “injurious to health”. Existing risk 
assessments (EFSA, 2015; VKM et al., 2019) have however, largely 
bypassed the question whether these same effects could be adverse (or 
not adverse) in children. 
Concerning sleep, intervention studies in adults have shown signif-
icant effects on sleep disruption at doses corresponding to the equivalent 
of ~4 cups of coffee (400 mg) 6 h before bed-time (Drake et al., 2013), 
~1 cup of coffee (100 mg, ~1.4 mg/kg bw) before bedtime (Landolt 
et al., 1995a) and even at ~2 cups (200 mg) of coffee administered early 
in the morning (Landolt et al., 1995b). One limitation of existing in-
terventions focusing on caffeine and sleep in adults is that they are 
typically conducted in few selected healthy individuals (n ~10–20) with 
only few doses tested (Drake et al., 2013; Drapeau et al., 2006; Landolt 
et al., 1995a, 1995b). One strength of our study is that it provides a more 
direct measure of the biological gradient (or dose-response) between 
habitual consumption of caffeine and self-reported sleep in the general 
adolescent population. The clear reduction in sleep duration observed in 
our study is entirely in line with the above-mentioned results from in-
terventions in adults. Although we lacked information on timing of 
intake, consumption is likely to tilt towards the afternoon as use of en-
ergy drinks is prohibited at schools. Still, our use of the 1.4 mg/kg bw 
cut-off for sleep requires balanced interpretation as exact timing of 
consumption relative to bedtime was lacking and one can only assume 
that exceedance of this limit close to bedtime may have occurred for 
some but not all of those participants. 
Previous risk assessments and opinion by health authorities have 
largely ignored observational findings on sleep in children, citing use of 
self-reported measures, lack of prospective studies and risk of bias (COT, 
2018; EFSA, 2015; VKM et al., 2019). In the case of caffeine, lower risk 
of bias would not be expected for prospective studies as the effects of 
caffeine on sleep are measured in hours but not days, weeks or years. 
Concerning other limitations, the Committee of Toxicity (COT) sug-
gested in their statement from 2018 that risky behaviour among energy 
drink consumers and “confounding by other dietary and life-style factors as 
well as psychological effects such as expectation” might account for such 
findings on sleep in children (COT, 2018). Although some confounding 
can be expected, this statement overlooks the fact that associations re-
ported between caffeine and sleep among children (Cusick et al., 2020; 
Pollak and Bright, 2003) are fully in line with effects observed in 
experimental studies in adults, which makes it less plausible that these 
associations are fully explained by such biases alone. As with all 
observational studies some confounding may occur, for example, 
through higher caffeine intake among children who have sleeping dif-
ficulties due to behavioural problems or being exposed to difficult 
conditions at home or in school. In our study we could address this 
concern in some detail by exploring associations with sleep across strata 
of conditions that reflect children’s behaviours or well-being that could 
affect sleep. In those analyses we observed consistent associations, 
measured in both relative and absolute terms, across these strata. The 
consistency of our findings across these strata makes confounding by 
factors affecting the children’s life-style, behaviour or their well-being 
seem less likely. 
Previous surveys among adolescents vary considerably by design and 
reporting, making direct comparison difficult (EFSA, 2015; Vercammen 
et al., 2019; Verster and Koenig, 2018; VKM et al., 2019). Based on the 
National Health and Nutrition Examination Survey (NHANES) the 
prevalence of daily energy drink consumption among US adolescents 
(12–19 years, n = 9 911) increased from 0.4% in 2003 to 2.3% in 2016 
(Vercammen et al., 2019). In comparison a total of 4.2% of our 
13-15-year-old participants reported to drink at least one energy drink 
per day. In another large (n ~32000) survey among adolescents across 
14 European countries the prevalence of energy drink consumption, 
defined as having one energy drink over the past year or more, was 68% 
(EFSA, 2015). Based on this broad definition, the mean caffeine intake 
from energy drinks among energy drink consumers was 24 mg/day 
compared to 46 mg/day in our study, where consumers were not defined 
as broadly. 
When assessing the impact of energy drinks, the use of average intake 
estimates can lead to spurious conclusions. For example, by averaging 
consumption of different caffeine containing beverages (EFSA, 2015), 
EFSA concluded that the relative contribution of energy drinks to total 
daily caffeine exposure among adolescents across 14 different European 
countries was marginal (median across all countries: 0%, range: 0–13%) 
compared to chocolate drinks (29%, 8–92%) coffee (19%, 3–53%), tea 
(22%, 1–65%) and cola drinks (17%, 0–42%). This approach, which has 
also been used in a recent risk assessment from Norway (VKM, 2019) 
and in a review on caffeine intake among US adolescents (Ahluwalia and 
Herrick, 2015), has contributed to the widespread opinion that the 
contribution of caffeine from energy drinks is neglectable, and reduction 
in intake can best be achieved by targeting other beverages (COT, 2018; 
Verster and Koenig, 2018). Such use of statistics to characterise intake is, 
however, misleading for skewed data. That is, for energy drinks, there is 
a large group of non-consumers where other dietary sources fully 
explain caffeine intake. However, for the minority of regular energy dink 
consumers, relative sources of intake will inevitably differ, and con-
clusions on relative contributions of different caffeine sources should be 
evaluated specifically for this group but not diluted over the whole 
population. Regardless of how others have interpreted their data (EFSA, 
2015; VKM et al., 2019), simple calculations show that for children and 
adolescents one to two servings of energy drinks per day, depending on 
body weight, result in exposure above the limit of no safety concern, 
regardless of other caffeine sources (Seifert et al., 2011). 
Our study is subject to several limitation. The quantification on 
caffeine intake is subject to assumptions on both serving sizes and 
caffeine concentrations that vary considerably. Self-reported intakes are 
also prone to recall bias. However, the uncertainty in our estimates 
should be similar to those used in previous risk assessments (EFSA, 
2015; VKM et al., 2019) or reviews that are either based on 24 h recalls, 
questions on frequency of intake as in our study, or both. At least for 
adults, the two methods have been shown to be relatively strongly 
correlated (r~0.7) (Schliep et al., 2013). Reasonable correlation (r~0.6) 
between self-reported caffeine intake and some metabolites of caffeine 
in urine (Rybak et al., 2015) have also been reported. Concerning our 
measures on sleep, a study in 9–17 year old US children (n = 285) 
comparing self-reported measures of sleep with polysomnography 
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reported intraclass correlation of 0.7 and 0.5 for sleep duration and la-
tency, respectively (Combs et al., 2019). Compared to the poly-
somnography, the children systematically overestimated their sleep 
duration (mean ~30 min). Although these results suggest reasonable 
degree of validity for self-reported sleep duration, the assessment was 
based on recall for a single day but not questions on average over several 
nights as in our study. Acknowledging the uncertainties associated with 
our self-reported measures, the exact values of our estimates should be 
interpreted with some caution. 
In conclusion, in a large nationwide survey on caffeinated beverages 
we observed strong association between total caffeine intake and self- 
reported duration and difficulty falling asleep among 13 to 15-year- 
old Icelandic adolescents. In contrast to conclusions from previous risk 
assessments high caffeine intake above the limit for effects on sleep and 
level of no safety concern was largely explained by consumption of 
energy drinks. In the case of children, access and availability to many 
commercial products and services are restricted if they are suspected to 
adversely affect their well-being. Given the known dependencies and 
withdrawal symptoms experienced by some regular caffeine users as 
well as documented effects of poor sleep on children’s well-being, a 
question can be raised concerning the intentional addition of caffeine to 
beverages and foods marketed to, and specifically directed at, children. 
This issue appears to fall outside the scope of existing food safety reg-
ulations and the fact that previous risk assessments have largely ignored 
this issue perhaps reflects the limitation of relying on pure toxicological 
principles for addressing children’s wellbeing. 
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